Burn Ointment Market to Reach USD 1.47 Billion by 2029 as Burn Care Awareness and Advanced Treatment Demand Rise

Burn Ointment Market Overview

The Burn Ointment Market was valued at USD 971.87 million in 2022 and is expected to reach approximately USD 1.47 billion by 2029, expanding at a CAGR of 6.1% from 2023 to 2029, according to Maximize Market Research. The market is benefiting from the increasing incidence of burn injuries, rising awareness of burn treatment options, and growing healthcare expenditure on wound management. Burn ointments are widely used as first-aid and supportive treatment products across hospitals, clinics, and home-care environments. Increasing awareness regarding early burn management and the availability of topical antibiotics, silver-based formulations, and iodine-based products are supporting market expansion.

The market also presents significant opportunities through the development of advanced wound-care products. Rising demand for effective infection prevention, improved healing outcomes, and convenient topical treatments is encouraging companies to strengthen their product portfolios. Advanced wound dressings, antimicrobial technologies, biologics, and innovative topical formulations can expand the treatment options available to patients and healthcare professionals. Growing healthcare access in emerging economies, particularly in Asia Pacific, represents another important opportunity as burn-care infrastructure and awareness continue to improve.

* See What’s Driving Market Growth: https://www.maximizemarketresearch.com/request-sample/107774/ 

U.S. Market Trends and Investment

The United States remains a major market for burn ointments, supported by established healthcare infrastructure, specialized burn centers, and significant demand for wound-care products. In 2025, the American Burn Association continued strengthening standardized burn-care practices and quality initiatives, while its Burn Care Quality Platform provided national benchmark data from participating burn centers. The 2025 platform included data covering 32,993 cases from 2024 and 162,799 cases from 2020–2024 across 114 burn centers, highlighting the scale of specialized burn care in the country. Product innovation also remained active. NEOSPORIN continues to offer dedicated burn-relief antibiotic ointment containing bacitracin zinc, neomycin sulfate, polymyxin B sulfate, and pramoxine hydrochloride for minor burns, demonstrating continued consumer demand for convenient first-aid burn treatment. Johnson & Johnson also announced in March 2025 that it planned to invest more than USD 55 billion in U.S. manufacturing, research and development, and technology over four years, representing a 25% increase over the previous four-year period.

Market Segmentation

Based on Product, the Topical Antibiotics segment is expected to hold the largest market share by 2029. The segment benefits from extensive use in home-care settings and the rising prevalence of burn wounds globally. Products containing ingredients such as mafenide acetate, bacitracin, mupirocin, neomycin, polymyxin B, nitrofurazone, and nystatin are used across different burn-care applications. Increasing awareness of infection prevention and the availability of over-the-counter and prescription topical antibiotic formulations are expected to support continued demand.

Burn Ointment Market Key Players:
1. Johnson & Johnson
2. Sun Pharmaceutical Industries Ltd.
3. Dr.Morepen
4. Smith & Nephew
5. ConvaTec Inc.
6. GlaxoSmithKline PLC (GSK)
7. Pfizer, Inc.
8. Perrigo Company PLC
9. Sun Pharmaceutical Industries Ltd.
10. Cipla Limited
11. Mankind Pharma Ltd.
12. Kinetic Concepts, Inc.
13. Anika Therapeutics
14. B. Braun Melsungen AG
15. Cardinal Health
16. Integra LifeSciences Corporation

Competitive Analysis

The MMR report identifies Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Dr. Morepen, Smith & Nephew, and ConvaTec Inc. as the top key players in the Burn Ointment Market. The supplied report does not publish verified individual market-share percentages for these companies, so exact company shares have not been fabricated.

Johnson & Johnson continues to maintain significant healthcare investment. In 2025, the company announced more than USD 55 billion of planned U.S. investment over four years across manufacturing, R&D, and technology, creating broader opportunities for healthcare-product innovation.

Sun Pharmaceutical Industries Ltd. continues expanding its global pharmaceutical and specialty-care operations. Its 2025 milestones included the acquisition of Checkpoint Therapeutics in the United States and the launch of LEQSELVI, strengthening its U.S. specialty healthcare presence.

Dr. Morepen continues to operate across healthcare and pharmaceutical businesses, with its 2025–26 corporate structure including pharmaceutical, medical-device, and healthcare subsidiaries, supporting its broader healthcare product ecosystem.

Smith & Nephew accelerated advanced wound-care innovation during 2025. It launched the CENTRIO Platelet-Rich-Plasma System in the United States and expanded its wound-management portfolio. The company also began launching ALLEVYN Ag+ SURGICAL, an antimicrobial silver dressing incorporating ComfortSTAY and HighFLEX technologies.

ConvaTec strengthened its advanced wound-care pipeline through products including ConvaFoam, Aquacel ConvaFiber, and ConvaNiox. In October 2025, it announced plans to invest more than USD 1 billion in R&D facilities over the next decade, including USD 600 million in the U.S. and £500 million in the U.K., supporting next-generation wound-care innovation.

Regional Analysis

United States: North America is expected to dominate the global Burn Ointment Market through 2029, with the United States holding a significant regional position because of its well-established healthcare infrastructure and incidence of burn injuries. Specialized burn centers, treatment standards, and ongoing product innovation further support market development.

United Kingdom: The U.K. is an important wound-care market supported by an established healthcare system and investment in advanced wound-management technologies. ConvaTec's planned £500 million R&D investment in the U.K., including a new Manchester technology and innovation center, demonstrates continued investment in advanced wound-care development.

Germany and France: Both countries benefit from established healthcare systems, specialized clinical services, and growing adoption of advanced wound-care technologies. Demand for antimicrobial products and evidence-based wound-management solutions is expected to support market opportunities.

Japan: Japan's ageing population and sophisticated healthcare infrastructure create opportunities for wound-care products designed to support efficient treatment and improved healing outcomes.

Related Reports: 

NLP in Healthcare and Life Sciences Market https://www.maximizemarketresearch.com/market-report/nlp-in-healthcare-and-life-sciences-market/228435/ 

Anti-Wrinkle Products Market https://www.maximizemarketresearch.com/market-report/anti-wrinkle-products-market/228942/ 

Personalized LASIK Surgery Market https://www.maximizemarketresearch.com/market-report/personalized-lasik-surgery-market/230753/ 

Conclusion

The Burn Ointment Market is positioned for steady growth as burn incidence, treatment awareness, healthcare accessibility, and demand for infection-prevention solutions increase. With the market projected to reach USD 1.47 billion by 2029, topical antibiotics are expected to remain the leading product segment. The strongest future opportunities are likely to emerge from advanced antimicrobial formulations, improved topical delivery technologies, combination therapies, and integration with modern wound-care systems. Companies investing in clinically supported products, innovative antimicrobial technologies, and expanded access to burn-care solutions are likely to benefit from the market's long-term development.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com